The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analyses of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC).
 
Bernard J. Escudier
Honoraria - Bayer; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Exelixis; GlaxoSmithKline; Novartis; Pfizer
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Thomas Powles
Honoraria - Bristol-Myers Squibb; Novartis; Roche/Genentech
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche; Merck
Research Funding - AstraZeneca/MedImmune; GlaxoSmithKline; Roche/Genentech
 
Nizar M. Tannir
Honoraria - GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Pfizer
Travel, Accommodations, Expenses - Exelixis; GlaxoSmithKline; Novartis; Pfizer
 
Ian D. Davis
Research Funding - Astellas Pharma (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Frede Donskov
Research Funding - GlaxoSmithKline; Novartis; Pfizer
 
Viktor Grünwald
Honoraria - Bayer; Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Pfizer; Roche
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Daniel Yick Chin Heng
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Janssen; Novartis; Pfizer
 
Thomas Hutson
Employment - Texas Oncology
Honoraria - Bayer/Onyx; Dendreon; GlaxoSmithKline; Johnson & Johnson; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer/Onyx; GlaxoSmithKline; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Bayer/Onyx; Dendreon; GlaxoSmithKline; Johnson & Johnson; Medivation; Pfizer
Research Funding - GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Medivation (Inst); Pfizer (Inst)
 
Bohuslav Melichar
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Dimitry Nosov
Consulting or Advisory Role - Pfizer
 
Brian I. Rini
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Immatics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Pamela Salman
Speakers' Bureau - Merck; Novartis
 
Cora N. Sternberg
Honoraria - Argos Therapeutics; Astellas Pharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Janssen; Lilly/ImClone; Merck; Millennium; Novartis; Oncogenex; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Novartis
 
Cezary Szczylik
Employment - Astellas Pharma; Bayer; Pfizer
Honoraria - Astellas Pharma; Bayer; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bayer; Novartis; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Novartis; Pfizer
 
Pascal Wolter
Honoraria - Bristol-Myers Squibb; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Research Funding - Pfizer
 
Alan M Arroyo
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Milan Mangeshkar
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Neeraj Agarwal
Research Funding - amgen (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst); TRACON Pharma (Inst)
Other Relationship - Exelixis; Medivation; Takeda
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb (Inst); GlaxoSmithKline; Merck; Novartis; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst); TRACON Pharma (Inst)